Jasper Therapeutics, Inc. (JSPR)

Price & Market Data

Price: $0.90

Daily Change: +$0.0274 / 3.04%

Daily Range: $0.87 - $1.02

Market Cap: $25,281,128

Daily Volume: 680,185

Performance Metrics

1 Week: -3.48%

1 Month: -9.94%

3 Months: -36.39%

6 Months: -47.99%

1 Year: -81.62%

YTD: -51.42%

About Jasper Therapeutics, Inc. (JSPR)

Gain a deep understanding of Jasper Therapeutics, Inc. (JSPR). The stock is trading at 0.90, showing a daily change of +$0.0274 / 3.04%. Its market capitalization is 25,281,128. Performance over 1-week (-3.48%) and 6-month (-47.99%) periods offer valuable insights.

Company Details

Employees: 22

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.

Selected stocks

Ring Energy, Inc. (REI)

Laird Superfood, Inc. (LSF)

AIxCrypto Holdings, Inc. (AIXC)

Onfolio Holdings Inc. (ONFO)

Eaton Vance Senior Income Trust (EVF)